Core Viewpoint - Rocket Lab's stock experienced a significant decline due to the delay in the test launch of its new Neutron rocket, despite a strong earnings report and a year-over-year revenue increase [1][4][5]. Group 1: Stock Performance - Rocket Lab shares fell 33% in November, attributed to the postponement of the Neutron rocket's debut to 2026 [1][5]. - Despite the recent drop, Rocket Lab shares have increased by 100% over the past twelve months [2]. - The current stock price is $48.64, with a market cap of $26 billion [3]. Group 2: Revenue and Growth - Rocket Lab's revenue surged by 48% year-over-year last quarter, reaching $155 million [4]. - The company has a backlog of over $500 million in contracted revenue from its Electron rocket, which is currently flying 20 missions per year [3][4]. Group 3: Future Prospects - The Neutron rocket is expected to significantly increase revenue per launch and compete directly with SpaceX [5]. - The company has burned $232 million in free cash flow over the last twelve months while developing the Neutron and its launch sites [6]. - Rocket Lab's stock is considered overvalued with a high price-to-sales ratio, trading at a market cap of $25.6 billion against trailing revenue of $550 million [7].